Velsera is a company based in the United States, founded in 2023, operating within the Business Services industry with a focus on research and development, information technology, and clinical laboratory services. The company employs between 501 and 1,000 individuals and has reported revenue of approximately $43.7 million. Velsera specializes in providing secure software solutions for the biotech and pharmaceutical sectors, particularly in molecular diagnostics. Their FastFinder platform is designed with a strong emphasis on data security, incorporating multiple layers of protection, regular audits, and adherence to industry best practices. The platform supports secure communication and data storage, ensuring compliance with regulations governing sensitive healthcare data. Velsera's commitment to security is further demonstrated by its documented procedures for development, production, and security management, which are externally audited to maintain high standards. The company’s focus on safeguarding confidential research and healthcare-related data positions it as a reliable partner in the clinical research and diagnostics landscape.